Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.

Sara E MoleAngela SchulzEben BadoeSamuel F BerkovicEmily C de Los ReyesSimon DulzPaul GissenNorberto GuelbertCharles M LourencoHeather L MasonJonathan W MinkNoreen MurphyMiriam NickelJoffre E OlayaMaurizio ScarpaIngrid E SchefferAlessandro SimonatiNicola SpecchioIna Von LöbbeckeRaymond Y WangRuth E Williams

Published in: Orphanet journal of rare diseases (2021)

This program provides robust evidence- and consensus-driven guidelines that can be used by all healthcare professionals involved in the management of patients with CLN2 disease and other neurodegenerative disorders. This addresses the clinical need to complement other information available.

Keyphrases

end stage renal disease
clinical practice
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
quality improvement
healthcare
combination therapy